Revised estimates of overdiagnosis from the Canadian National Breast Screening Study.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Preventive Medicine

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ypmed.2016.06.033PMID 27374944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Walking the tightrope: communicating overdiagnosis in modern healthcare

  2016cited by this paper
• Breast-cancer screening--viewpoint of the IARC Working Group.

  2015cited by this paper
• Study designs for determining and comparing sensitivities of disease screening tests

  2015cited by this paper
• Counterpoint: Overdiagnosis in breast cancer screening.

  2014cited by this paper
• Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial

  2014cited by this paper
• Reduction in late‐stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer

  2014cited by this paper
• Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study

  2014cited by this paper
• Quantifying the benefits and harms of screening mammography.

  2014cited by this paper
• Lead time and overdiagnosis.

  2014cited by this paper
• Abolishing mammography screening programs? A view from the Swiss Medical Board.

  2014cited by this paper
• Is carcinoma in situ a precursor lesion of invasive breast cancer?

  2014cited by this paper
• Arguments against mammography screening continue to be based on faulty science.

  2014cited by this paper
• Influence of Study Features and Methods on Overdiagnosis Estimates in Breast and Prostate Cancer Screening

  2013cited by this paper
• The benefits and harms of breast cancer screening: an independent review

  2013cited by this paper
• Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis

  2013cited by this paper
• Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time

  2013cited by this paper
• Risk of ischemic heart disease in women after radiotherapy for breast cancer.

  2013cited by this paper
• Effect of three decades of screening mammography on breast-cancer incidence.

  2012cited by this paper
• The benefits and harms of breast cancer screening: an independent review.

  2012cited by this paper
• Overdiagnosis in cancer.

  2010cited by this paper
• Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study

  2006cited by this paper
• Report of the International Workshop on Screening for Breast Cancer.

  1993cited by this paper
• Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.

  1992cited by this paper
• Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.

  1992cited by this paper

• Is maximizing the promotion of breast cancer screening ethically and morally justifiable?

  2025cites this paper
• Are We Losing the Final Fight against Cancer?

  2024cites this paper
• Conversations in Breast Cancer Screening: An Exploration of Age, Density, and Emerging Technologies

  2024cites this paper
• Screening for breast cancer: a systematic review update to inform the Canadian Task Force on Preventive Health Care guideline

  2024cites this paper
• Harms and benefits of mammographic screening for breast cancer in Brazil

  2024cites this paper
• Overdiagnosis Due to Screening Mammography for Breast Cancer among Women Aged 40 Years and Over: A Systematic Review and Meta-Analysis

  2023cites this paper
• Impact of Breast Cancer Screening on 10-Year Net Survival in Canadian Women Age 40-49 Years

  2023cites this paper
• Quantifying Diminishing Return to Mammography Screenings Using Individual Medical Histories

  2023cites this paper
• Breast Cancer: Impact of New Treatments?

  2023cites this paper
• Progress and Remaining Gaps in the Early Detection and Treatment of Breast Cancer

  2023influential citation
• Behaviour within a Clinical Trial and Implications for Mammography Guidelines.

  2022influential citation
• Breast Cancer Screening: Is There Room for De-escalation?

  2022cites this paper
• Effectiveness of mammography screening for women aged 40–49

  2022cites this paper
• Overdetection of Breast Cancer

  2022influential citation
• Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort

  2022cites this paper
• The Role of Screening Mammography in Addressing Disparities in Breast Cancer Diagnosis, Treatment, and Outcomes

  2021cites this paper
• Mammograms and Mortality: How Has the Evidence Evolved?

  2021cites this paper
• In women aged 40 to 48 y, annual mammography vs. usual care reduced breast cancer mortality at 10 but not 23 y

  2021cites this paper
• Major failings of trial procedures and quality of screening fatally compromise the results of the Canadian National Breast Screening Studies

  2021cites this paper
• Overdiagnosis and Risks of Breast Cancer Screening.

  2021cites this paper
• Cancer screening – Why do we still debate about the benefits?

  2020cites this paper
• Breast cancer overdiagnosis in stop-screen trials: More uncertainty than previously reported

  2020cites this paper
• Final results of the UK Age trial on breast cancer screening age.

  2020cites this paper
• Physician Perspectives on Mammography Screening for Average-Risk Women: “Like a Double-Edged Sword”

  2020cites this paper
• Physician Perspectives on Mammography Screening for Average-Risk Women: “Like a Double-Edged Sword” Mammography Screening for Average-Risk Women

  2020cites this paper
• Breast cancer over-diagnosis: an adverse consequence of mammography screening - highlights of the 2018 Kyoto Breast Cancer Consensus Conference.

  2019cites this paper
• The history of cancer screening.

  2019cites this paper
• NBER WORKING PAPER SERIES BEHAVIOR WITHIN A CLINICAL TRIAL AND IMPLICATIONS FOR MAMMOGRAPHY GUIDELINES

  2019influential citation
• A partially observable Markov chain framework to estimate overdiagnosis risk in breast cancer screening: Incorporating uncertainty in patients adherence behaviors

  2019cites this paper
• [Discrepancies and overdiagnosis in breast cancer organized screening. A "methodology" systematic review].

  2018cites this paper
• Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer

  2018cites this paper
• Behavior within a Clinical Trial and Implications for Mammography Guidelines

  2018cites this paper
• Overdiagnosis: causes and consequences in primary health care.

  2018cites this paper
• Accuracy of mammography and clinical breast examination in the implementation of breast cancer screening programs in Colombia.

  2018cites this paper
• Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening

  2018cites this paper
• Guidelines for early detection of breast cancer in Brazil. II - New national recommendations, main evidence, and controversies.

  2018cites this paper
• Guidelines for early detection of breast cancer in Brazil. I - Development methods.

  2018cites this paper
• Surdiagnostic : causes et conséquences en soins primaires

  2018cites this paper
• The role of screening mammography in the era of modern breast cancer treatment

  2018cites this paper
• Benefits and harms of breast cancer screening with mammography in women aged 40–49 years: A systematic review

  2017influential citation
• Emerging Trends in Family History of Breast Cancer and Associated Risk

  2017cites this paper
• Breast-Cancer Tumor Size and Screening Effectiveness.

  2017cites this paper
• Prevalence of incidental breast cancer and precursor lesions in autopsy studies: a systematic review and meta-analysis

  2017cites this paper
• Breast-Cancer Tumor Size and Screening Effectiveness.

  2017cites this paper
• Comment on ‘Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study’

  2017cites this paper
• Preventing overdiagnosis in mammography screening – a public health perspective

  2017cites this paper
• Towards more effective online information support for mammography screening decisions.

  2017cites this paper
• What’s Involved with Wanting to Be Involved? Comparing Expectations for Public Engagement in Health Policy across Research and Care Contexts

  2017cites this paper
• A Review and Comparative Analysis of Information Targeted to the General Public on the Websites of Breast Screening Programs in Canada

  2017cites this paper